• Home
  •  / Boston Scientific

Boston Scientific

OverviewSuggest Edit

Boston Scientific is a developer, manufacturer, and marketer of medical devices. It offers pacemakers, defibrillators, remote patient monitoring and diagnostic monitoring solutions, spinal cord stimulator systems, a range of catheters, Chronic Total Occlusion (CTO) systems, direct visualization systems, fiducial markers, forceps, guidewires, lasers, fibers, lifting agents, needles, penile prosthesis, retrieval devices, slings, snares, stents, ureteroscopes, vein ablation solutions, thrombectomy systems, sphincterotomes, and other products. The company caters to endoscopy, interventional cardiology, neuromodulation, peripheral interventions, rhythm management, and urology and pelvic health segments.
TypePublic
Founded1979
HQMarlborough, MA, USMap
Websitebostonscientific.com
Employee Ratings4.2More
Overall CultureAMore
View Jobs (1,206)

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2021)41,000(+8%)
Job Openings1,206
Revenue (FY, 2021)$11.9 B(+20%)
Share Price (May 2022)$40.1
Cybersecurity ratingCMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Boston Scientific

Michael F Mahoney

Michael F Mahoney

Chairman and Chief Executive Officer
Daniel J. Brennan

Daniel J. Brennan

Executive Vice President and Chief Financial Officer
Edward MacKey

Edward MacKey

Executive Vice President, Global Operations
Art Butcher

Art Butcher

Executive Vice President and President, Asia Pacific
Wendy Carruthers

Wendy Carruthers

Senior Vice President, Human Resources
Jodi Eddy

Jodi Eddy

Senior Vice President and Chief Information and Digital Officer
Show more

Boston Scientific Office Locations

Boston Scientific has offices in Marlborough, Arden Hills, Maple Grove, San Jose and in 25 other locations
Marlborough, MA, US (HQ)
300 Boston Scientific Way, Marlborough
Arden Hills, MN, US
4100 Hamline Ave N
Maple Grove, MN, US
1 Scimed Pl
San Jose, CA, US
150 Baytech Dr
Santa Clarita, CA, US
25155 Rye Canyon Loop, Valencia
Spencer, IN, US
780 Brookside Dr
Show all (29)

Boston Scientific Financials and Metrics

Boston Scientific Revenue

Embed Graph
View revenue for all periods
Boston Scientific's revenue was reported to be $11.89 b in FY, 2021
USD

Revenue (Q1, 2022)

3.0b

Gross profit (Q1, 2022)

2.1b

Gross profit margin (Q1, 2022), %

68.4%

Net income (Q1, 2022)

110.0m

EBIT (Q1, 2022)

466.0m

Market capitalization (25-May-2022)

55.9b

Closing stock price (25-May-2022)

40.1

Cash (30-Sept-2021)

1.9b

EV

63.0b
Boston Scientific's current market capitalization is $55.9 b.
Annual
USDFY, 2019FY, 2020FY, 2021

Revenue

10.7b9.9b11.9b

Revenue growth, %

9%(8%)

Cost of goods sold

3.1b3.5b3.7b

Gross profit

7.6b6.4b8.2b
Quarterly
USDQ1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022

Revenue

2.5b2.0b2.7b2.8b3.1b2.9b3.0b

Cost of goods sold

806.0m791.0m869.0m894.0m945.0m900.0m955.0m

Gross profit

1.7b1.2b1.8b1.9b2.1b2.0b2.1b

Gross profit Margin, %

68%61%67%68%69%69%68%
show all
Annual
USDFY, 2018FY, 2019FY, 2020

Cash

146.0m217.0m1.7b

Accounts Receivable

1.6b1.8b1.5b

Inventories

1.2b1.6b1.4b

Current Assets

4.0b4.7b6.7b
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Cash

139.0m123.0m277.0m370.0m1.7b2.0b2.0b2.7b1.9b

Accounts Receivable

1.6b1.7b1.8b1.6b1.5b1.6b1.6b1.7b1.7b

Inventories

1.2b1.3b1.6b1.6b1.5b1.5b1.4b1.4b1.6b

Current Assets

6.2b6.3b4.8b4.8b5.8b6.2b6.1b6.8b6.2b
show all
Annual
USDFY, 2018FY, 2019FY, 2020

Net Income

1.7b4.7b(82.0m)

Depreciation and Amortization

894.0m1.0b1.1b

Inventories

(83.0m)(290.0m)(65.0m)

Accounts Payable

(631.0m)111.0m88.0m
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Net Income

424.0m578.0m704.0m11.0m341.0m527.0m946.0m

Depreciation and Amortization

268.0m531.0m803.0m

Inventories

(115.0m)(100.0m)(315.0m)

Accounts Payable

(10.0m)187.0m275.0m
show all
USDFY, 2018

Debt/Equity

0.6 x

Debt/Assets

0.2 x

Financial Leverage

2.4 x
Show all financial metrics

Boston Scientific Operating Metrics

FY, 2018FY, 2019FY, 2020

Countries

130120120

Medical Institutions Covered (U.S.)

35 k37 k35 k

Patent Applications

5 k6 k6 k

Patents Issued

19 k21 k18 k
Show all operating metrics

Boston Scientific Acquisitions / Subsidiaries

Company NameDateDeal Size
Baylis Medical CompanyOctober 06, 2021$1.75 b
Devoro Medical, Inc.September 21, 2021$320 m
Lumenis Surgical DivisionMarch 03, 2021$1.1 b
Preventice SolutionsJanuary 21, 2021$925 k
FarapulseSeptember 21, 2020
VertiFlexMay 09, 2019$465 m
BTGNovember 19, 2018$4.2 b
AugmenixSeptember 10, 2018$600 m
SpaceOARSeptember 07, 2018$600 m
VenitiAugust 08, 2018$160 m
Show more

Boston Scientific Revenue Breakdown

Embed Graph

Boston Scientific revenue breakdown by business segment: 31.3% from MedSurg, 40.9% from Cardiovascular, 27.7% from Rhythm Management and 0.1% from Other

Boston Scientific revenue breakdown by geographic segment: 17.4% from APAC, 21.2% from EMEA, 58.1% from U.S. and 3.3% from Other

Human Capital Metrics

Source: www.bostonscientific.com, craft.co, www.sec.gov, craft.co
Embed Graph
Show all human capital metrics

Boston Scientific Cybersecurity Score

Cybersecurity ratingPremium dataset

C

78/100

Learn more about our premium products
SecurityScorecard logo

Boston Scientific Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

60-79

out of 100

Learn more about our premium products
CSRHub logo

Boston Scientific Online and Social Media Presence

Boston Scientific's Trends

Embed Graph

Boston Scientific Company Culture

  • Overall Culture

    A

    76/100

  • CEO Rating

    A+

    85/100

  • Compensation

    B+

    75/100

  • Diversity

    B+

    74/100

Learn more on Comparably

Boston Scientific News and Updates

May 13, 2022

Outlook on the Catheter Global Market to 2027 - Featuring Teleflex, Boston Scientific and Terumo Among Others

DUBLIN, May 13, 2022 /PRNewswire/ -- The "Global Catheter Market, Size, Share, Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering. This report provides an all-encompassing...
May 02, 2022

Boston Scientific to Participate in Bank of America Global Healthcare Conference

MARLBOROUGH, Mass., May 2, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Bank of America's Global Healthcare Conference on Thursday, May 12. Dan Brennan, executive vice president and chief financial officer, and Lauren Tengler, vice president, Investor...
April 27, 2022

Boston Scientific tops estimates for Q1, sending shares up 3.3% premarket

Boston Scientific Corp. shares rose 3.3% premarket Wednesday, after the medical device maker reported lower earnings for the first quarter than a year ago but still beat consensus estimates. The company posted net income of $97 million, or 7 cents a share, for the quarter, down from $327 million, o…
April 26, 2022

What To Expect From Boston Scientific Stock Following Q1 Earnings?

Revenues expected to be slightly above the consensus estimates Trefis estimates Boston Scientific’s Q1 2022 revenues to be around $3.0 billion, slightly above the $2.9 billion consensus estimate.
April 01, 2022

Boston Scientific Announces Conference Call Discussing First Quarter 2022 Results

MARLBOROUGH, Mass., April 1, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2022, on Wednesday, April 27, 2022, at 8:00 a.m. EDT. The call will be...
March 16, 2022

This Software Company Is Likely To Offer Better Returns Over Boston Scientific Stock

We think that Intuit stock, a company that specializes in financial and tax preparation software, currently is a better pick compared to medical devices maker Boston Scientific stock (NYSE: BSX), despite INTU being more expensive of the two with its P/S ratio of 11.2x, compared to 5.0x for BSX...
Show more

Boston Scientific Blogs

April 27, 2022

Boston Scientific Receives FDA Clearance for the EMBOLD™ Fibered Detachable Coil

April 11, 2022

Boston Scientific Receives FDA Approval for Next-Generation Image Guided Programming Software for Deep Brain Stimulation Therapy

STIMVIEW™ XT, developed in collaboration with Brainlab AG, provides clinicians with real-time, 3D visualization and stimulation of brain anatomy
March 16, 2022

Boston Scientific Announces Pricing Terms of Its Cash Tender Offer

March 08, 2022

Boston Scientific Announces Completion of €3.0 Billion Offering of Senior Notes

February 28, 2022

Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX™ LAAC Device

February 15, 2022

Boston Scientific Closes Acquisition of Baylis Medical Company Inc.

Show more

 Boston Scientific Frequently Asked Questions

  • When was Boston Scientific founded?

    Boston Scientific was founded in 1979.

  • Who are Boston Scientific key executives?

    Boston Scientific's key executives are Michael F Mahoney, Daniel J. Brennan and Edward MacKey.

  • How many employees does Boston Scientific have?

    Boston Scientific has 41,000 employees.

  • What is Boston Scientific revenue?

    Latest Boston Scientific annual revenue is $11.9 b.

  • What is Boston Scientific revenue per employee?

    Latest Boston Scientific revenue per employee is $290 k.

  • Who are Boston Scientific competitors?

    Competitors of Boston Scientific include Baxter International, Johnson & Johnson and Abbott.

  • Where is Boston Scientific headquarters?

    Boston Scientific headquarters is located at 300 Boston Scientific Way, Marlborough, Marlborough.

  • Where are Boston Scientific offices?

    Boston Scientific has offices in Marlborough, Arden Hills, Maple Grove, San Jose and in 25 other locations.

  • How many offices does Boston Scientific have?

    Boston Scientific has 29 offices.